abstract |
The invention relates to 17α-alkyl-17β-oxy-estra-1,3,5(10)-trienes having an anti-oestrogen action, of general formula (I). The invention also relates to 17-oxo-estra-1,3,5(10)-trienes and 17β-hydroxy-estra-1,3,5(10)-trienes as intermediates for producing the inventive estratrienes. The invention further relates to the use of 17α-alkyl-17β-oxy-estratrienes for the production of medicaments and pharmaceutical preparations containing at least one 17α-alkyl-17β-oxy-estratriene and at least one pharmaceutically acceptable carrier. |